Published May 4, 2023 | Version v1
Dataset Open

BRD8 is a therapeutic vulnerability for overcoming resistance to dual ER/HER2 blockade therapy in HR+/HER2+ breast cancer

Authors/Creators

  • 1. McArdle Laboratory for Cancer Research

Description

.rda file for Seurat object of scRNA-seq data from BT474 breast cancer cell lines treated with DMSO, Neratinib, Fulvestrant, and a combination of Neratinib and Fulvestrant.

Files

Files (356.8 MB)

Name Size
md5:f92bd0cc4ba697713d009bae884ff860
356.8 MB Download